ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q1SCImago #4,543Top JournalReview JournalHybrid

Expert Opinion on Biological Therapy

Acronym:eobt
•
Abbreviation (ISO):EXPERT OPIN. BIOL. THER
•
Identifier (ISSN):1471-2598(Print)/1744-7682(Online)
•
Publisher:Taylor and Francis Ltd.
Clarivate IF (2026)
4– 0
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIETop Tier
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Expert Opinion on Biological Therapy

WoS Q2
24683.9720183.5820193.2220204.3920215.5920224.620233.620244202542026
Annual Impact Factor Metric
Current (2026):4
Scopus SJR & RankScopus Q1
1.045
#4,543

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
112

112 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
127articles/year
7.1% Gold OA•32.98% Original Research

Aims & Scope

Expert Opinion on Biological Therapy (1471-2598; 1744-7682) is a MEDLINE-indexed, international journal publishing peer-reviewed research across all aspects of biological therapy. Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development. The audience consists of scientists and managers in the healthcare and biopharmaceutical industries and others closely involved in the development and application of biological therapies for the treatment of human disease. The journal welcomes: Reviews covering therapeutic antibodies and vaccines, peptides and proteins, gene therapies and gene transfer technologies, cell-based therapies and regenerative medicine Drug evaluations reviewing the clinical data on a particular biological agent Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practice Comprehensive coverage in each review is complemented by the unique Expert Collection format and includes the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results; Article Highlights – an executive summary of the author’s most critical points.

Topics Covered (Recognized by AI)
MedicineBiologyGeneticsInternal MedicineImmunologyChemistryPathologyBiochemistryImmune SystemBioinformaticsOncology & Cancer ResearchSurgeryCancer ResearchPathology & DiseasesAntibodies & ImmunologyCell BiologyPsychologyPharmacology

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q2
Rank71/180
IndexSCIE
JCRSCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q2
Rank70/191
IndexSCIE
JCISCIE2026

BIOTECHNOLOGY & APPLIED MICROBIOLOGY

Q3
Rank113/180
IndexSCIE
JCISCIE2026

MEDICINE, RESEARCH & EXPERIMENTAL

Q3
Rank110/191
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF4
Articles / Year104
Total Citations25
2025
IF4
Articles / Year115
Total Citations328
2024
IF3.6
Articles / Year146
Total Citations872
2023
IF4.6
Articles / Year111
Total Citations1,241
2022
IF5.589
Articles / Year111
Total Citations1,972

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,543Scopus Q1SCImago Profile
Scopus Coverage:2001-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.045

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
3.31

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,379 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,403
3-Year Documents401
Citable Documents337

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Clinical BiochemistryQ1
Drug DiscoveryQ1
PharmacologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
2区BIOTECHNOLOGY & APPLIED MICROBIOLOGY
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Expert Opinion on Biological Therapy (acronym: eobt, abbr: EXPERT OPIN. BIOL. THER, ISSN: 1471-2598) is a peer-reviewed international scholarly journal in the field of Medicine, published by Taylor and Francis Ltd. in England since 2001. The periodical holds a Journal Impact Factor (JIF) of 4.00, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.045 (Q1), an H-index of 112.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 127 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,379 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Taylor and Francis Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
2001
Indexing & Databases
SCIEScopusPubMed
Editorial Address
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 5952fa9a-e56f-4dde-bee4-5f16b7a90260
Database Updated: 2026-09-28